NASDAQ:NRCIB - National Research Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Today's Range N/A50-Day Range N/A52-Week Range N/AVolume20,669 shsAverage Volume1,844 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. Read More… Industry, Sector and Symbol Stock Exchange NASDAQ Industry Commercial physical research Sub-IndustryHealth Care Services SectorBusiness Services Current SymbolNASDAQ:NRCIB Previous Symbol CUSIP63737230 CIK70487 Webhttp://www.nrchealth.com/ Phone402-475-2525Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive NRCIB News and Ratings via Email Sign-up to receive the latest news and ratings for NRCIB and its competitors with MarketBeat's FREE daily newsletter. National Research (NASDAQ:NRCIB) Frequently Asked Questions What is National Research's stock symbol? National Research trades on the NASDAQ under the ticker symbol "NRCIB." How were National Research's earnings last quarter? National Research Co. (NASDAQ:NRCIB) posted its earnings results on Thursday, May, 4th. The business services provider reported $0.26 earnings per share for the quarter, missing analysts' consensus estimates of $0.81 by $0.55. The business services provider earned $30.28 million during the quarter. View National Research's Earnings History. Has National Research been receiving favorable news coverage? News coverage about NRCIB stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. National Research earned a daily sentiment score of -4.5 on InfoTrie's scale. They also gave news coverage about the business services provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term. View News Stories for National Research. Who are some of National Research's key competitors? Some companies that are related to National Research include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Davita (DVA), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG). What other stocks do shareholders of National Research own? Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Bioanalytical Systems (BASI), Bruker (BRKR), IDEXX Laboratories (IDXX), National Research (NRCIA), Thermo Fisher Scientific (TMO), Aethlon Medical (AEMD), Advanced Energy Industries (AEIS), Adverum Biotechnologies (ADVM), ADMA Biologics (ADMA) and Adaptimmune Therapeutics (ADAP). Who are National Research's key executives? National Research's management team includes the folowing people: Mr. Michael D. Hays, Founder, CEO & Director (Age 63)Mr. Steven D. Jackson, Pres (Age 42)Mr. Kevin R. Karas CPA, Principal Accounting Officer, Sr. VP of Fin., CFO, Treasurer & Sec. (Age 60)Ms. Helen Hrdy, Sr. VP of Client Services What is National Research's official website? The official website for National Research is http://www.nrchealth.com/. How can I contact National Research? National Research's mailing address is 1245 Q STREET, LINCOLN NE, 68508. The business services provider can be reached via phone at 402-475-2525. MarketBeat Community Rating for National Research (NASDAQ NRCIB)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 472 (Vote Outperform)Underperform Votes: 454 (Vote Underperform)Total Votes: 926MarketBeat's community ratings are surveys of what our community members think about National Research and other stocks. Vote "Outperform" if you believe NRCIB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NRCIB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/25/2020 by MarketBeat.com StaffFeatured Article: How prevalent are 12b-1 fees?
